In addition, the lower G0S2 expression group clearly showed better over survival than the higher G0S2 expression group for all WHO grade II–IV gliomas (p = 1.181e-8) and for WHO grade II/III lower grade gliomas (p = 0.01371) (Fig 1E). The gene discussed is G0S2; the disease is central nervous system cancer.